Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling

Bing Qing Deng, Ying Luo, Xin Kang, Chang Bin Li, Christophe Morisseau, Jun Yang, Kin Sing Stephen Lee, Jian Huang, Da Yong Hu, Ming Yu Wu, Ai Peng, Bruce D. Hammock, Jun Yan Liu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Acute kidney injury (AKI) causes severe morbidity and mortality for which new therapeutic strategies are needed. Docosahexaenoic acid (DHA), arachidonic acid (ARA), and their metabolites have various effects in kidney injury, but their molecular mechanisms are largely unknown. Here, we report that 14 (15)-epoxyeicosatrienoic acid [14 (15)-EET] and 19 (20)-epoxydocosapentaenoic acid [19 (20)-EDP], the major epoxide metabolites of ARA and DHA, respectively, have contradictory effects on kidney injury in a murine model of ischemia/ reperfusion (I/R)-caused AKI. Specifically, 14 (15)-EET mitigated while 19 (20)-EDP exacerbated I/R kidney injury. Manipulation of the endogenous 19 (20)-EDP or 14 (15)-EET by alteration of their degradation or biosynthesis with selective inhibitors resulted in anticipated effects. These observations are supported by renal histological analysis, plasma levels of creatinine and urea nitrogen, and renal NGAL. The 14 (15)-EET significantly reversed the I/R-caused reduction in glycogen synthase kinase 3β (GSK3β) phosphorylation in murine kidney, dose-dependently inhibited the hypoxia/reoxygenation (H/R)-caused apoptosis of murine renal tubular epithelial cells (mRTECs), and reversed the H/R-caused reduction in GSK3β phosphorylation in mRTECs. In contrast, 19 (20)-EDP dose-dependently promoted H/R-caused apoptosis and worsened the reduction in GSK3β phosphorylation in mRTECs. In addition, 19 (20)-EDP was more metabolically stable than 14 (15)-EET in vivo and in vitro. Overall, these epoxide metabolites of ARA and DHA function conversely in I/R-AKI, possibly through their largely different metabolic stability and their opposite effects in modulation of H/R-caused RTEC apoptosis and GSK3β phosphorylation. This study provides AKI patients with promising therapeutic strategies and clinical cautions.

Original languageEnglish (US)
Pages (from-to)12608-12613
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number47
DOIs
StatePublished - Nov 21 2017

Fingerprint

Glycogen Synthase Kinase 3
Docosahexaenoic Acids
Epoxy Compounds
Acute Kidney Injury
Kidney
Acids
Phosphorylation
Arachidonic Acid
Reperfusion
Ischemia
Epithelial Cells
Apoptosis
Cell Hypoxia
Wounds and Injuries
Reperfusion Injury
Urea
Creatinine
Nitrogen
14,15-epoxy-5,8,11-eicosatrienoic acid
Morbidity

Keywords

  • Epoxydocosapentaenoic acid
  • Epoxyeicosatrienoic acid
  • GSK3β phosphorylation
  • Renal tubular epithelial cells
  • siRNA

ASJC Scopus subject areas

  • General

Cite this

Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling. / Deng, Bing Qing; Luo, Ying; Kang, Xin; Li, Chang Bin; Morisseau, Christophe; Yang, Jun; Lee, Kin Sing Stephen; Huang, Jian; Hu, Da Yong; Wu, Ming Yu; Peng, Ai; Hammock, Bruce D.; Liu, Jun Yan.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 47, 21.11.2017, p. 12608-12613.

Research output: Contribution to journalArticle

Deng, BQ, Luo, Y, Kang, X, Li, CB, Morisseau, C, Yang, J, Lee, KSS, Huang, J, Hu, DY, Wu, MY, Peng, A, Hammock, BD & Liu, JY 2017, 'Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling', Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 47, pp. 12608-12613. https://doi.org/10.1073/pnas.1705615114
Deng, Bing Qing ; Luo, Ying ; Kang, Xin ; Li, Chang Bin ; Morisseau, Christophe ; Yang, Jun ; Lee, Kin Sing Stephen ; Huang, Jian ; Hu, Da Yong ; Wu, Ming Yu ; Peng, Ai ; Hammock, Bruce D. ; Liu, Jun Yan. / Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 47. pp. 12608-12613.
@article{f244593763b74f24b307d8a41ce56671,
title = "Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling",
abstract = "Acute kidney injury (AKI) causes severe morbidity and mortality for which new therapeutic strategies are needed. Docosahexaenoic acid (DHA), arachidonic acid (ARA), and their metabolites have various effects in kidney injury, but their molecular mechanisms are largely unknown. Here, we report that 14 (15)-epoxyeicosatrienoic acid [14 (15)-EET] and 19 (20)-epoxydocosapentaenoic acid [19 (20)-EDP], the major epoxide metabolites of ARA and DHA, respectively, have contradictory effects on kidney injury in a murine model of ischemia/ reperfusion (I/R)-caused AKI. Specifically, 14 (15)-EET mitigated while 19 (20)-EDP exacerbated I/R kidney injury. Manipulation of the endogenous 19 (20)-EDP or 14 (15)-EET by alteration of their degradation or biosynthesis with selective inhibitors resulted in anticipated effects. These observations are supported by renal histological analysis, plasma levels of creatinine and urea nitrogen, and renal NGAL. The 14 (15)-EET significantly reversed the I/R-caused reduction in glycogen synthase kinase 3β (GSK3β) phosphorylation in murine kidney, dose-dependently inhibited the hypoxia/reoxygenation (H/R)-caused apoptosis of murine renal tubular epithelial cells (mRTECs), and reversed the H/R-caused reduction in GSK3β phosphorylation in mRTECs. In contrast, 19 (20)-EDP dose-dependently promoted H/R-caused apoptosis and worsened the reduction in GSK3β phosphorylation in mRTECs. In addition, 19 (20)-EDP was more metabolically stable than 14 (15)-EET in vivo and in vitro. Overall, these epoxide metabolites of ARA and DHA function conversely in I/R-AKI, possibly through their largely different metabolic stability and their opposite effects in modulation of H/R-caused RTEC apoptosis and GSK3β phosphorylation. This study provides AKI patients with promising therapeutic strategies and clinical cautions.",
keywords = "Epoxydocosapentaenoic acid, Epoxyeicosatrienoic acid, GSK3β phosphorylation, Renal tubular epithelial cells, siRNA",
author = "Deng, {Bing Qing} and Ying Luo and Xin Kang and Li, {Chang Bin} and Christophe Morisseau and Jun Yang and Lee, {Kin Sing Stephen} and Jian Huang and Hu, {Da Yong} and Wu, {Ming Yu} and Ai Peng and Hammock, {Bruce D.} and Liu, {Jun Yan}",
year = "2017",
month = "11",
day = "21",
doi = "10.1073/pnas.1705615114",
language = "English (US)",
volume = "114",
pages = "12608--12613",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "47",

}

TY - JOUR

T1 - Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling

AU - Deng, Bing Qing

AU - Luo, Ying

AU - Kang, Xin

AU - Li, Chang Bin

AU - Morisseau, Christophe

AU - Yang, Jun

AU - Lee, Kin Sing Stephen

AU - Huang, Jian

AU - Hu, Da Yong

AU - Wu, Ming Yu

AU - Peng, Ai

AU - Hammock, Bruce D.

AU - Liu, Jun Yan

PY - 2017/11/21

Y1 - 2017/11/21

N2 - Acute kidney injury (AKI) causes severe morbidity and mortality for which new therapeutic strategies are needed. Docosahexaenoic acid (DHA), arachidonic acid (ARA), and their metabolites have various effects in kidney injury, but their molecular mechanisms are largely unknown. Here, we report that 14 (15)-epoxyeicosatrienoic acid [14 (15)-EET] and 19 (20)-epoxydocosapentaenoic acid [19 (20)-EDP], the major epoxide metabolites of ARA and DHA, respectively, have contradictory effects on kidney injury in a murine model of ischemia/ reperfusion (I/R)-caused AKI. Specifically, 14 (15)-EET mitigated while 19 (20)-EDP exacerbated I/R kidney injury. Manipulation of the endogenous 19 (20)-EDP or 14 (15)-EET by alteration of their degradation or biosynthesis with selective inhibitors resulted in anticipated effects. These observations are supported by renal histological analysis, plasma levels of creatinine and urea nitrogen, and renal NGAL. The 14 (15)-EET significantly reversed the I/R-caused reduction in glycogen synthase kinase 3β (GSK3β) phosphorylation in murine kidney, dose-dependently inhibited the hypoxia/reoxygenation (H/R)-caused apoptosis of murine renal tubular epithelial cells (mRTECs), and reversed the H/R-caused reduction in GSK3β phosphorylation in mRTECs. In contrast, 19 (20)-EDP dose-dependently promoted H/R-caused apoptosis and worsened the reduction in GSK3β phosphorylation in mRTECs. In addition, 19 (20)-EDP was more metabolically stable than 14 (15)-EET in vivo and in vitro. Overall, these epoxide metabolites of ARA and DHA function conversely in I/R-AKI, possibly through their largely different metabolic stability and their opposite effects in modulation of H/R-caused RTEC apoptosis and GSK3β phosphorylation. This study provides AKI patients with promising therapeutic strategies and clinical cautions.

AB - Acute kidney injury (AKI) causes severe morbidity and mortality for which new therapeutic strategies are needed. Docosahexaenoic acid (DHA), arachidonic acid (ARA), and their metabolites have various effects in kidney injury, but their molecular mechanisms are largely unknown. Here, we report that 14 (15)-epoxyeicosatrienoic acid [14 (15)-EET] and 19 (20)-epoxydocosapentaenoic acid [19 (20)-EDP], the major epoxide metabolites of ARA and DHA, respectively, have contradictory effects on kidney injury in a murine model of ischemia/ reperfusion (I/R)-caused AKI. Specifically, 14 (15)-EET mitigated while 19 (20)-EDP exacerbated I/R kidney injury. Manipulation of the endogenous 19 (20)-EDP or 14 (15)-EET by alteration of their degradation or biosynthesis with selective inhibitors resulted in anticipated effects. These observations are supported by renal histological analysis, plasma levels of creatinine and urea nitrogen, and renal NGAL. The 14 (15)-EET significantly reversed the I/R-caused reduction in glycogen synthase kinase 3β (GSK3β) phosphorylation in murine kidney, dose-dependently inhibited the hypoxia/reoxygenation (H/R)-caused apoptosis of murine renal tubular epithelial cells (mRTECs), and reversed the H/R-caused reduction in GSK3β phosphorylation in mRTECs. In contrast, 19 (20)-EDP dose-dependently promoted H/R-caused apoptosis and worsened the reduction in GSK3β phosphorylation in mRTECs. In addition, 19 (20)-EDP was more metabolically stable than 14 (15)-EET in vivo and in vitro. Overall, these epoxide metabolites of ARA and DHA function conversely in I/R-AKI, possibly through their largely different metabolic stability and their opposite effects in modulation of H/R-caused RTEC apoptosis and GSK3β phosphorylation. This study provides AKI patients with promising therapeutic strategies and clinical cautions.

KW - Epoxydocosapentaenoic acid

KW - Epoxyeicosatrienoic acid

KW - GSK3β phosphorylation

KW - Renal tubular epithelial cells

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=85034568842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034568842&partnerID=8YFLogxK

U2 - 10.1073/pnas.1705615114

DO - 10.1073/pnas.1705615114

M3 - Article

AN - SCOPUS:85034568842

VL - 114

SP - 12608

EP - 12613

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 47

ER -